WCM
SRGA

Wedge Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Wedge Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,419
Closed -$1.47M – 540
2021
Q1 		$1.47M Buy
22,419
+6,502
+41% +$454K 0.02% 295
2020
Q4 		$1.05M Hold
15,917
– – 0.01% 327
2020
Q3 		$864K Buy
+15,917
New +$1.22M 0.01% 314
2019
Q3 		– Sell
-10,709
Closed -$1.36M – 626
2019
Q2 		$1.36M Sell
10,709
-2,122
-17% -$306K 0.02% 304
2019
Q1 		$2.31M Buy
12,831
+2,014
+19% +$291K 0.03% 280
2018
Q4 		$1.2M Hold
10,817
– – 0.01% 311
2018
Q3 		$1.46M Hold
10,817
– – 0.01% 314
2018
Q2 		$1.49M Hold
10,817
– – 0.01% 303
2018
Q1 		$1.49M Sell
10,817
-373
-3% -$50.8K 0.01% 293
2017
Q4 		$1.38M Buy
11,190
+2,807
+33% +$385K 0.01% 316
2017
Q3 		$1.14M Hold
8,383
– – 0.01% 336
2017
Q2 		$1.47M Buy
+8,383
New +$1.19M 0.01% 287
2016
Q1 		– Sell
-10,117
Closed -$1.21M – 610
2015
Q4 		$1.21M Buy
10,117
+3,904
+63% +$504K 0.01% 302
2015
Q3 		$1.06M Sell
6,213
-510
-8% -$97.7K 0.01% 326
2015
Q2 		$1.3M Buy
6,723
+2,156
+47% +$400K 0.01% 292
2015
Q1 		$677K Buy
4,567
+284
+7% +$43.2K 0.01% 385
2014
Q4 		$668K Buy
4,283
+370
+9% +$53.3K 0.01% 400
2014
Q3 		$561K Sell
3,913
-1,027
-21% -$149K 0.01% 435
2014
Q2 		$645K Sell
4,940
-950
-16% -$121K 0.01% 396
2014
Q1 		$721K Sell
5,890
-1,017
-15% -$110K 0.01% 348
2013
Q4 		$733K Buy
6,907
+1,937
+39% +$188K 0.01% 340
2013
Q3 		$558K Buy
4,970
+1,060
+27% +$120K 0.01% 365
2013
Q2 		$441K Buy
+3,910
New +$478K 0.01% 391

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Wedge Capital Management's SRGA Position: Q2 2021 in Review

Wedge Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 22,419 shares — an estimated $1.47M sold.

Wedge Capital Management first reported a position in SRGA in Q2 2013 and held it in 23 quarters. The position peaked at $2.31M in Q1 2019. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.

  • Wedge Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Wedge Capital Management sold 22,419 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $1.47M.
  • Wedge Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 23 quarters.
  • Wedge Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $2.31M in Q1 2019.
  • 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.

Based on Wedge Capital Management's 13F filing for Q2 2021, filed 14 Jul 2021.